Home | Welcome to Contract Pharma   
Last Updated Sunday, December 21 2014

Print

Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published February 24, 2010
The Centers for Disease Control & Prevention (CDC) has selected Sentry BioPharma Services to store and distribute flu vaccine to support its national strategic reserve. Read More »
Published December 22, 2009
DSM makes enzyme for Mayoly Spindler at Capua facility. Read More »
Published September 21, 2009
DOR BioPharma has been awarded a $9.4 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). Read More »
Published August 20, 2008
Bristol-Myers Squibb and PDL BioPharma, Inc. entered an agreement for the global development and commercialization of PDL’s anti-CS1 antibody, elotuzumab, currently in Phase I development for multiple myeloma.     Elotuzumab o… Read More »
Published September 26, 2007
Baxter BioPharma Solutions recently completed the lyophilization capacity expansion at their cytotoxic contract manufacturing facility in Halle, Germany. The expansion increased their total cytotoxic lyophilization capacity to four dedicated lyophili… Read More »
Published August 29, 2007
PDL BioPharma, Inc., following a business and portfolio review, has changed its strategic focus to the discovery and development of novel antibodies in oncology and select immunological diseases. According to a company statement, it will realign its… Read More »
Published October 6, 2006
Array BioPharma, Inc. has appointed April H. Teitelbaum, M.D., MS, FACP, to the newly created position of vice president of clinical development, oncology. Dr. Teitelbaum will oversee the medical strategy and clinical development of the company's onc… Read More »
Published April 11, 2006
Array BioPharma and AstraZeneca have selected a third compound for their small molecule MEK anti-cancer program, triggering a $1 million milestone payment by AstraZeneca. The second compound was selected in January 2006, also triggering a $1 million… Read More »
Published January 4, 2006
Wyeth Pharmaceuticals and Trubion Pharmaceuticals, Inc. have formed a strategic alliance for the discovery, development and commercialization of novel biopharmaceutical products to treat inflammatory disease and cancer. The alliance will utilize Trub… Read More »
Published September 25, 2014
Will align conjugation and manufacture of drug linkers with sterile fill/finish services Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On